HomeEndocrinologyNew approach to ID obesity could avoid misdiagnosing millions

New approach to ID obesity could avoid misdiagnosing millions

Experts suggest that combining body mass index (BMI) with other measurements and tests for obesity would lead to better care and outcomes, and result in fewer misdiagnoses, reports The Guardian.

They said the alternative far more accurately distinguished healthy people from those with harmful excess body fat.

Experts have long considered body mass index a blunt instrument for defining obesity, leading to concerns that substantial numbers of people with excess body fat are missed while others who are healthy are wrongly diagnosed.

The new approach, which combines BMI with other body measurements and organ function tests, suggests BMI alone misses obesity in 5%-9% of adults, while wrongly diagnosing the condition in as many as 3%.

“This misclassification can account for tens of millions of people, so the inaccuracy of BMI is a big problem at scale and also for individuals,” said Francisco Rubino, a professor of metabolic and bariatric surgery at King’s College London.

BMI is calculated by dividing weight in kilograms by height in metres squared. Globally, about 1.6bn people are classified as overweight, meaning their BMI falls between 25 and 29.9, and nearly a billion with a BMI of 30 or more are considered obese. Two-thirds of British adults and more than 70% American adults are overweight or obese based on BMI alone.

Rubino and his colleagues drew on health records from more than 800 000 people in the UK, US, China and Spain to test a diagnostic approach for obesity that he and other world experts proposed last year in a Lancet Commission report. They used the records to track people’s health for up to 15 years.

Under the new definition, someone with a BMI of more than 40 is considered obese, but doctors check people with a lower BMI for excess body fat by looking at their waist measurement.

A BMI of 30-plus with a raised waist measurement or waist-to-height ratio counts as obese, as does a BMI from 25 to 29.9 if waist measurement and waist-to-height ratio are high. In most countries, a raised waist measurement means more than 102cm for men and 88cm for women, while thresholds for a high waist-to-height ratio are about 0.57.

In a second step of the diagnosis, doctors distinguish between clinical obesity, meaning an active disease where excess body fat is already impairing organ function, and pre-clinical obesity, where the extra fat is a health risk but has yet to cause problems.

Obesity levels rose only slightly overall under the new definition, and only a quarter to a third of obese people, or 5% to 10% of the wider population, who had clinical obesity and a substantially higher risk of death.

The approach allows doctors to distinguish between healthy and sick people who have the same BMI, they wrote in their findings, published in Nature. Three people with a BMI of 32, for example, would all be classed as obese but would have very different diagnoses.

One might have no excess body fat and be healthy, another could have excess fat but no organ dysfunction and have pre-clinical obesity, and the third could have excess fat and organ dysfunction and be clinically obese.

Study details

Validation of clinical and preclinical obesity across global cohorts

An Pan, Shengping Yang, Rafael Ramos, Francisco Rubino et al.

Published in Nature on 11 November 2026

Abstract

In 2025, a Lancet Commission proposed distinguishing clinical obesity, defined by adiposity-related organ dysfunction, from preclinical obesity, defined by excess adiposity with preserved function, and recommended using anthropometric measures beyond body mass index (BMI) to confirm obesity status1. Here we report the comparative performance of this framework versus conventional BMI-based classification using prevalence, incidence and mortality data from 844,108 adults across four cohorts in China, the UK, the USA and Spain. Complementing BMI with waist circumference and waist-to-height ratio data showed that BMI alone overestimated obesity in 1.2–3.1% and underestimated it in 5.2–8.6% of participants across cohorts. The combined anthropometric definition increased overall obesity prevalence by 3.3–7.4% relative to BMI-based classification. Clinical obesity accounted for 22.7–31.3% of total obesity, with an overall population prevalence of 5.6–10.9%. A large proportion of individuals (between 77.4% and 91.3%) with preclinical obesity at baseline showed no progression to clinical obesity over 10 years. Increased mortality risk was associated with the combined anthropometric definition of obesity, but not with BMI-only obesity. Clinical obesity was associated with substantially higher all-cause mortality (hazard ratio 1.69, 95% confidence interval 1.64–1.73), whereas preclinical obesity conferred only modest risk (1.19, 1.14–1.24). These findings support the global adoption of the Lancet Commission diagnostic framework to improve obesity care and policy.

 

Nature article – Validation of clinical and preclinical obesity across global cohorts (Restricted access)

 

Lancet Commission report

 

The Guardian article – BMI alternative for identifying obesity ‘could prevent misdiagnosis in millions’ (Open access)

 

See more from MedicalBrief archives:

 

Two body measurements flagged for death risk, but neither is BMI – Chinese study

 

Moving away from BMI as a health risk indicator

 

BMI a weak indicator of fatty tissue content, large analysis finds

 

Fat mass index, not BMI, associated with CVD events in people with diabetes

MedicalBrief — our free weekly e-newsletter

We'd appreciate as much information as possible, however only an email address is required.